Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13380
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Savige, Judy A | en |
dc.contributor.author | Chang, L | en |
dc.contributor.author | Smith, C L | en |
dc.contributor.author | Duggan, J C | en |
dc.date.accessioned | 2015-05-16T03:13:14Z | |
dc.date.available | 2015-05-16T03:13:14Z | |
dc.date.issued | 1993-01-01 | en |
dc.identifier.citation | Leukemia & Lymphoma; 9(1-2): 49-54 | en |
dc.identifier.govdoc | 8477201 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/13380 | en |
dc.description.abstract | A cutaneous or systemic vasculitis occurs in myelodysplasia as well as in myeloproliferative and lymphoproliferative disorders. The most common lesion is a leucocytoclastic vasculitis, with neurological or joint involvement occurring less often. The vasculitis may appear contemporaneously with or precede the clinical onset of the blood dyscrasia. Occasionally the lesions respond dramatically to the use of steroids but in general, patients with vasculitis have a worse prognosis than those with uncomplicated myelodysplasia. Vasculitis and myelodysplasia appear together too often for the association to be coincidental and the vasculitis in most cases cannot be attributed to intercurrent infections, therapeutic agents or a pre-existing rheumatological disorder. While autoantibodies are frequently present in myelodysplasia, and ANA and anti-neutrophil cytoplasm antibodies (ANCA) are found in other vasculitides, neither of these antibodies is associated with the vasculitis of myelodysplasia. There has however been one report of ANCA in Sweet's syndrome a non-vasculitic skin condition that also occurs in the myelodysplastic syndromes. | en |
dc.language.iso | en | en |
dc.subject.other | Adult | en |
dc.subject.other | Aged | en |
dc.subject.other | Alkylating Agents.adverse effects | en |
dc.subject.other | Anemia, Refractory, with Excess of Blasts.epidemiology | en |
dc.subject.other | Antigen-Antibody Complex.analysis | en |
dc.subject.other | Autoantibodies.immunology | en |
dc.subject.other | Cyclophosphamide.adverse effects | en |
dc.subject.other | Cytoplasm.immunology | en |
dc.subject.other | Female | en |
dc.subject.other | Humans | en |
dc.subject.other | Incidence | en |
dc.subject.other | Male | en |
dc.subject.other | Middle Aged | en |
dc.subject.other | Myelodysplastic Syndromes.chemically induced.complications.immunology | en |
dc.subject.other | Neutrophils.immunology | en |
dc.subject.other | Prognosis | en |
dc.subject.other | Sweet Syndrome.immunology | en |
dc.subject.other | Vasculitis.etiology.immunology | en |
dc.title | Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Leukemia & lymphoma | en |
dc.identifier.affiliation | University Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia | en |
dc.identifier.doi | 10.3109/10428199309148503 | en |
dc.description.pages | 49-54 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/8477201 | en |
dc.type.austin | Journal Article | en |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.